Metronidazole Prices June 2023
Product
|
Category |
Region |
Price |
Metronidazole |
Pharma API |
USA |
37977 USD/MT |
Metronidazole |
Pharma API |
China |
32503 USD/MT |
Metronidazole |
Pharma API |
Germany |
38869 USD/MT |
The price of metronidazole in the US for Q2 2023 measured 37977 USD/MT.
The price of metronidazole in China stands at 32503 USD/MT for Q2 2023.
In Germany, metronidazole was quoted at 38869 USD/MT for prices in Q2 of 2023.
Metronidazole Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Metronidazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of metronidazole pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of metronidazole at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of metronidazole price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing metronidazole price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Metronidazole Market Analysis
The global metronidazole market size reached US$ 150.3 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 207.6 Million, at a projected CAGR of 3.70% during 2023-2032.
- The global rise in bacterial infections, particularly anaerobic bacteria that cause conditions like bacterial vaginosis and dental infections, is a primary driver of the metronidazole market.
- Metronidazole is recommended by several health organizations, including the World Health Organization (WHO), for the treatment of various protozoal and bacterial infections.
- The patent expiry of branded metronidazole has led to the emergence of cost-effective generic versions, broadening the accessibility and affordability of the treatment.
- The aging population is more susceptible to infections such as Clostridium difficile, often requiring effective antimicrobial treatments like metronidazole, which is anticipated to propel the demand for metronidazole.
- Global investments in expanding and upgrading healthcare infrastructure have facilitated wider access to treatments including antibiotics like metronidazole.
- Increased public health campaigns and education about infectious diseases boost the understanding and demand for effective treatments. Metronidazole, known for its efficacy, benefits from such heightened awareness.
- Ongoing research and development aimed at expanding the applications of metronidazole to treat additional conditions drive its market growth.
- Strategic alliances and mergers & acquisitions among pharmaceutical companies are pivotal in driving the development and distribution of metronidazole.
- Obtaining regulatory approvals for new formulations and indications of metronidazole fosters market growth.
- As disposable incomes rise in emerging markets, more individuals can afford essential medications, including antibiotics like metronidazole.
Metronidazole News
The report covers the latest developments, updates, and trends impacting the global metronidazole market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in metronidazole production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the metronidazole price trend.
Latest developments in the metronidazole industry:
- April 2023: Zydus Lifesciences, a global pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for its Metronidazole Topical Cream, a treatment for rosacea. The approval marks a significant milestone for Zydus, as it expands its product portfolio and strengthens its presence in the U.S. market. The topical cream is a generic version of MetroCream, and its approval is expected to increase competition and provide patients with a more affordable treatment option for rosacea.
- September 2023: Likmez, a new metronidazole oral suspension, has been approved by the FDA for treating trichomoniasis, amebic dysentery, amebic liver abscess, and serious anaerobic infections in adults and pediatric patients. The ready-to-use liquid formulation in a strawberry peppermint flavor does not require refrigeration, providing a convenient alternative for patients who have difficulty swallowing tablets or capsules.
Product Description
Metronidazole is an antibacterial drug commonly applied to treat and prevent bacterial infections in the body and systemic protozoa as well. It is a synthetic nitroimidazole agent active against various anaerobes and protozoa, particularly indicated for treating conditions like bacterial vaginosis, trichomoniasis, and gut or skin infections. Metronidazole kills the bacteria and protozoa by interference in DNA synthesis.
The pH-dependent chemical reduction of the nitro group in metronidazole is a working mechanism by anaerobic bacteria and protozoa. It has properties such as attaining high concentrations inside the bacterial cell, relative stability in biological fluids, and low absorption if applied enterally. Some of the advantages of this antibiotic are that it is effective against anaerobic infection, often resistant to other antibiotics, relatively safe to use, and available in several formulations that include oral tablets, topical creams, or intravenous formulations for several therapeutic requirements.
Regional Coverage
The report provides a detailed analysis of the metronidazole market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the metronidazole price trend.
Global Metronidazole Price
The report offers a holistic view of the global metronidazole pricing trends in the form of metronidazole price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of metronidazole but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed metronidazole demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Metronidazole Price
European metronidazole prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed metronidazole price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Metronidazole Price
The analysis of metronidazole prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific metronidazole historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Metronidazole Price
The report explores the metronidazole pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on metronidazole prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Metronidazole Price
The metronidazole pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This metronidazole price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Metronidazole Price
The analysis of metronidazole prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Metronidazole |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Metronidazole Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of metronidazole pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting metronidazole price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The metronidazole price charts ensure our clients remain at the forefront of the industry.